Press release
Biosimilar Market Size, Historical Breakdown Data (2013-2019) and Forecast (2019-2025) | Revenue and Market Share by Manufacturers- Allergan plc, BIOCAD, Biocon, BioXpress Therapeutics and More
This report focuses on Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biosimilar market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
The global Biosimilar market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of 25.0% during 2019-2025.
This report focuses on Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biosimilar market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
Inquiry before buying a sample copy of Biosimilar Market Report 2019 @
https://www.marketresearchnest.com/report/enquirybuy/538101
The following manufacturers are covered:
• Allergan plc
• BIOCAD
• Biocon
• BioXpress Therapeutics
• Boehringer Ingelheim
• Celltrion
• Coherus BioSciences
• Dr. Reddy's Laboratories
• Genor BioPharma
• Intas Pharmaceuticals Limited
• Novartis
• Pfizer
• Reliance Life Sciences
By Products/Types:
• Human Growth Hormones
• Monoclonal Antibodies
• Insulin
• Peptides
• Erythropoietin
• Others
By Applications/End-Users:
• Oncology
• Chronic and Autoimmune Diseases
• Growth Hormone Deficiency
• Infectious Diseases
• Others
By Regions:
• North America
• Europe
• China
• Japan
Browse the full summary and TOC of Biosimilar Market @
https://www.marketresearchnest.com/Global-Biosimilar-Market-Research-Report-2019.html
Research Methodology and Data Sources for this report:
• This report consists of detailed overview of market segments, and comprehensive analysis.
• Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
• Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
• The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
• The market engineered data is verified and validated by a number of experts, both in-house and external.
• After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
• We have a dedicated team of Research Specialists and Sales Executives who are available for 24/7 support. We take pride in our team’s expertise. We are in a mode of constant learning and train our teams through various both internal and external learning interventions. This helps our team to provide best of service to our clients.
Request a sample copy of Biosimilar Market @
https://www.marketresearchnest.com/report/requestsample/538101
Table of Contents:
Executive Summary:
• Biosimilar Market Overview
• Global Biosimilar Market Competition by Manufacturers
• Global Biosimilar Production Market Share by Regions
• Global Biosimilar Consumption by Regions
• Global Biosimilar Production, Revenue, Price Trend by Type
• Global Biosimilar Market Analysis by Applications
• Company Profiles and Key Figures in Biosimilar Business
• Biosimilar Manufacturing Cost Analysis
• Marketing Channel, Distributors and Customers
• Market Dynamics
• Global Biosimilar Market Forecast
• Research Findings and Conclusion
• Methodology and Data Source
…. Table of Contents Continued
Related Report’s @ https://www.marketresearchnest.com/Global-Biosimilar-Monoclonal-Antibodies-Market-Research-Report-2019.html
https://www.marketresearchnest.com/Global-Oncology-Biosimilars-Market-Research-Report-2019.html
About us: - MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the Global and Southeast Asia’s most complete and recent database of expert insights on industries, organizations, products, and trends.
Contact us: - Mr. Jeet Jain, Sales Manager, sales@marketresearchnest.com ;
+1-240-284-8070, +44-20-3290-4151;
Connect with us: Google+ | LinkedIn | Twitter | Facebook
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilar Market Size, Historical Breakdown Data (2013-2019) and Forecast (2019-2025) | Revenue and Market Share by Manufacturers- Allergan plc, BIOCAD, Biocon, BioXpress Therapeutics and More here
News-ID: 1589543 • Views: …
More Releases from Market Research Nest
Condoms Market Witness Highest Growth in near future| Leading Key Players: Durex …
MarketResearchNest.com adds “In-depth Research Report of Global Condoms Market (2019 Version)” new report to its research database. The report spread across 127 pages with multiple tables and figures in it.
This report studies the Condoms market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find…
Future of Business Travel Insurance Market – A comprehensive study by Key Play …
MarketResearchNest.com adds “Global Business Travel Insurance Market Analysis 2013-2018 and Forecast 2019-2024” new report to its research database. The report spread across 76 pages with multiple tables and figures in it.
This report studies the Business Travel Insurance market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key…
Excellent Growth of Building Energy Management Systems Market Key Players- Schne …
MarketResearchNest.com adds “Global Building Energy Management Systems Market Analysis 2013-2018 and Forecast 2019-2024” new report to its research database. The report spread across 83 pages with multiple tables and figures in it.
This report studies the Building Energy Management Systems market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities…
Applicant Tracking Software Market is expected to double its market size in Upco …
MarketResearchNest.com adds “Global Applicant Tracking Software Market Analysis 2013-2018 and Forecast 2019-2024” new report to its research database. The report spread across 100 pages with multiple tables and figures in it.
This report studies the Applicant Tracking Software market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key…
More Releases for Biosimilar
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get…
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02…
Infliximab Biosimilar Insight, 2023 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…